High rates of hepatitis C virus (HCV) transmission are found in samples of people who inject drugs (PWID) throughout the world. The objective of this paper was to meta-analyze the effects of risk-reduction interventions on HCV seroconversion and identify the most effective intervention types.
The aim of the Network is to promote collaboration and exchange of information among the participants. This session was attended by 27 participants, both from NGOs and national governments and focused on two topics: harm reduction, and the Roma population. This report summarises the main…
The governments of Kazakhstan, Kyrgyzstan and Tajikistan decision to introduce substitution therapy programmes in their countries, despite the fact that the approach is new for the region and despite the position taken by the government of the Russian Federation regarding substitution therapy.…
This report outlines interventions for tackling hepatitis C in drug injecting populations in Europe and the surrounding area. These approaches are detailed in the context of the major common challenges faced across the region in addressing hepatitis C in drug injecting populations.
The ‘war on drugs’ has failed to eradicate drug markets and use. A growing number of policy options are available to address drug-related harms. The IDPC Guide brings together global evidence and best practice to assist national policy makers in the design and implementation of drug policies. The…
To promote and secure health in prison, testing for infectious diseases and vaccination is a major opportunity, and does have an impact on the health of the incarcerated, the correctional employees and the communities to which the inmates return.
This report includes a wide range of examples in which human rights standards and norms are infringed as a result of state activities pursued in the name of drug control. This clearly demonstrates the need for close attention to this issue within the UN system.
New Zealand Drug Foundation (Te Tuapapa Tarukino o Aotearoa) Policy Position, August 2007This paper presents the New Zealand Drug Foundation's policy position on reducing alcohol and other drugs (AOD) problems in New Zealand's criminal justice system.
UNODC, in collaboration with the National Drug Dependence Treatment Centre of India, has opened the country's first methadone maintenance treatment centre at the Civil Hospital in Kapurthala, in the State of Punjab, to treat heroin and opioid addicts.
Russia now accounts for two thirds of the Eastern Europe and Central Asian H.I.V. epidemic, the fastest growing in the world, but refuses to adopt an evidence-based harm reduction approach to drug use.
In the past few years, Russia has emerged as a self-proclaimed leader in the fight against HIV. Yet rates of HIV infection are skyrocketing among Russia’s own population as a result of the government’s negligence, discriminatory policies, and hostility towards evidence-based practices.
On World Hepatitis Day, EHRN calls for civil society to demand HCV treatment price reduction in Eastern Europe and Central Asia in order for the millions of people living with HCV to gain access to life saving drugs.
The war on drugs creates massive costs, resulting from the enforcement-led approach that puts organised crime in control of the trade. It is time to count these costs and explore the alternatives, using the best evidence available, to deliver a safer, healthier and more just world.